Karuna Therapeutics, Inc. Stock-Based Compensation
Karuna Therapeutics, Inc. reported Stock-Based Compensation of $74.60 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2024-02-22
- Karuna Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-12-31 was $22.79M, a 80.01% increase year-over-year.
- Karuna Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-09-30 was $18.30M, a 52.20% increase year-over-year.
- Karuna Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-06-30 was $18.00M, a 48.39% increase year-over-year.
- Karuna Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-03-31 was $15.51M, a 45.80% increase year-over-year.
- Karuna Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $74.60M, a 57.21% increase from fiscal 2022.
- Karuna Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $47.45M, a 59.17% increase from fiscal 2021.
- Karuna Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $29.81M, a 121.30% increase from fiscal 2020.
- Karuna Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $13.47M, a 7.18% increase from fiscal 2019.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $22.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $41.09M derived: sum of 2 quarters · filed 2024-02-22 | $59.09M derived: sum of 3 quarters · filed 2024-02-22 | $74.60M 10-K · filed 2024-02-22 |
| 2023-09-30 | $18.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $36.30M derived: sum of 2 quarters · filed 2023-11-02 | $51.81M 10-Q · filed 2023-11-02 | $64.47M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-06-30 | $18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $33.51M 10-Q · filed 2023-08-03 | $46.17M derived: sum of 3 quarters · filed 2024-02-22 | $58.19M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-03-31 | $15.51M 10-Q · filed 2023-05-04 | $28.17M derived: sum of 2 quarters · filed 2024-02-22 | $40.19M derived: sum of 3 quarters · filed 2024-02-22 | $52.32M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-12-31 | $12.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $24.68M derived: sum of 2 quarters · filed 2024-02-22 | $36.81M derived: sum of 3 quarters · filed 2024-02-22 | $47.45M 10-K · filed 2024-02-22 |
| 2022-09-30 | $12.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $24.15M derived: sum of 2 quarters · filed 2023-11-02 | $34.79M 10-Q · filed 2023-11-02 | $43.11M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $12.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $22.77M 10-Q · filed 2023-08-03 | $31.09M derived: sum of 3 quarters · filed 2024-02-22 | $39.29M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $10.64M 10-Q · filed 2023-05-04 | $18.96M derived: sum of 2 quarters · filed 2024-02-22 | $27.16M derived: sum of 3 quarters · filed 2024-02-22 | $34.63M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $8.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $16.52M derived: sum of 2 quarters · filed 2024-02-22 | $23.99M derived: sum of 3 quarters · filed 2024-02-22 | $29.81M 10-K · filed 2024-02-22 |
| 2021-09-30 | $8.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $15.67M derived: sum of 2 quarters · filed 2022-11-03 | $21.49M 10-Q · filed 2022-11-03 | $25.96M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $7.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $13.29M 10-Q · filed 2022-08-08 | $17.75M derived: sum of 3 quarters · filed 2023-02-23 | $21.90M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $5.82M 10-Q · filed 2022-05-05 | $10.29M derived: sum of 2 quarters · filed 2023-02-23 | $14.43M derived: sum of 3 quarters · filed 2023-02-23 | $17.66M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $4.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $8.61M derived: sum of 2 quarters · filed 2023-02-23 | $11.84M derived: sum of 3 quarters · filed 2023-02-23 | $13.47M 10-K · filed 2023-02-23 |
| 2020-09-30 | $4.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $7.37M derived: sum of 2 quarters · filed 2021-11-04 | $9.00M 10-Q · filed 2021-11-04 | $9.98M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $3.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $4.86M 10-Q · filed 2021-08-05 | $5.84M derived: sum of 3 quarters · filed 2022-02-24 | $7.48M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $1.63M 10-Q · filed 2021-05-06 | $2.62M derived: sum of 2 quarters · filed 2022-02-24 | $4.26M derived: sum of 3 quarters · filed 2022-02-24 | $11.10M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $981.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.62M derived: sum of 2 quarters · filed 2022-02-24 | $9.46M derived: sum of 3 quarters · filed 2022-02-24 | $12.57M 10-K · filed 2022-02-24 |
| 2019-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $8.48M derived: sum of 2 quarters · filed 2020-11-05 | $11.59M 10-Q · filed 2020-11-05 | $12.03M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $6.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $9.95M 10-Q · filed 2020-08-05 | $10.39M derived: sum of 3 quarters · filed 2021-02-25 | $10.79M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $3.10M 10-Q · filed 2020-05-07 | $3.54M derived: sum of 2 quarters · filed 2021-02-25 | $3.95M derived: sum of 3 quarters · filed 2021-02-25 | |
| 2018-12-31 | $441.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $848.00K derived: sum of 2 quarters · filed 2021-02-25 | $958.00K 10-K · filed 2021-02-25 | |
| 2018-09-30 | $407.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $517.00K 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | $110.00K 10-Q · filed 2019-08-08 |